Trial Profile
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2020
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 27 Dec 2019 Status changed from recruiting to completed.
- 13 Jan 2019 Status changed from not yet recruiting to recruiting.
- 21 Feb 2018 New trial record